Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Protein farnesyltransferase inhibitors prepared at Schering-Plough

Sep. 24, 1997

NCI to fund clinical trials of Pharmacyclics' Gd-Tex

Sep. 22, 1997

FDA panel recommends approval of Paxene

Sep. 22, 1997

Vaccine for colorectal cancer enters phase I/II

Sep. 22, 1997

Scotia signs licensing agreements for Foscan

Sep. 22, 1997

NCI sponsors trials of new treatment for MDR in multiple myeloma

Sep. 22, 1997

New antiapoptosis gene identified at Yale

Sep. 19, 1997

Advisory committee recommends approval of Photofrin for early-stage NSCLC

Sep. 19, 1997

Natural chemopreventive agent evaluated in rodent tumorigenesis models

Sep. 19, 1997

Oxford GlycoSciences' OGT-719 enters clinical testing

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...